While the H-CD8+T or ALDHlow-CD8+T could not significantly inhibit tumor growth, administration of the ALDHhigh-CD8+T cells could significantly inhibit tumor growth (P<0.05, compared to all other groups, Figure 4B). The gene discussed is CD8A; the disease is neoplasm.